Pressure on pharmaceuticals companies operating in China intensified yesterday as authorities broadened their probe into drug pricing and corruption.
在華經(jīng)營(yíng)的醫(yī)藥企業(yè)所受到的壓力昨日加劇，有關(guān)部門拓寬了其對(duì)藥品定價(jià)和腐敗行為的調(diào)查。
您已閱讀6%（191字），剩余94%（3218字）包含更多重要信息，訂閱以繼續(xù)探索完整內(nèi)容，并享受更多專屬服務(wù)。